Search - tctmd.com

Displaying 541 - 560 of 606

Sort: Relevancy | Date

News Daily News

In Older ACS Patients, Half-Dose Prasugrel as Safe as Clopidogrel But No More Effective

July 25, 2013

News Daily News

En Pacientes Ancianos, Media Dosis de Prasugrel es igual de Segura que el Clopidogrel aunque No Más Eficaz

July 25, 2013

News Daily News

HORIZONS-AMI: Bivalirudin, Taxus Improve Outcomes in LAD PCI Patients

Leah Lawrence

July 11, 2013

News Daily News

Stroke After STEMI Unusual But Carries Poor Prognosis

Yael L. Maxwell

May 03, 2013

News Daily News

Bone Marrow Stem Cells Not Effective Early or Late After AMI

Jason Kahn

April 26, 2013

News Daily News

Rivaroxaban Added to Dual Antiplatelet Therapy Cuts Stent Thrombosis in ACS Patients

Caitlin E. Cox

April 19, 2013

News Daily News

Danish Registry: Dabigatran Safe, Effective in Real-World Use

Caitlin E. Cox

April 05, 2013

News Daily News

Las Hemorragias ‘Molestas’ tras un IAM son Frecuenten e Influyen en la Calidad de Vida

Yael L. Maxwell

March 28, 2013

News Daily News

Remote Postconditioning Reduces AKI in NSTEMI Patients

March 15, 2013

News Conference News ACC 2013

STREAM: Fibrinolysis Strategy Effective for STEMI Patients Far From PCI Hospital

Yael L. Maxwell

March 09, 2013

News Daily News

AIDA STEMI Substudy Confirms No Advantage for Intracoronary Abciximab

February 27, 2013

News Daily News

Una Dosis Alta de Aspirina tras una PCI Primaria aumenta las Hemorragias No observandose Beneficio Isquémico alguno

L.A. McKeown

December 19, 2012

News Daily News

Genetic Alleles Affect Response to Prasugrel in ACS Patients

Jason Kahn

December 17, 2012

News Daily News

Los Alelos Genéticos Influyen en la Respuesta al Prasugrel de los Pacientes víctimas de un SCA

Jason Kahn

December 17, 2012

News Daily News

Los betabloqueadores reducen la mortalidad a largo plazo en pacientes de alto riesgo de STEMI

Yael L. Maxwell

December 13, 2012

News Daily News

Beta-Blockers Reduce Long-term Mortality in High-Risk STEMI Patients

Yael L. Maxwell

December 13, 2012

News Conference News TCT 2012

Second-Generation DES Safer, More Effective Than BMS in STEMI at 1 Year

October 31, 2012

News Daily News

Almost 1 in 10 STEMIs Caused by Stent Thrombosis

October 12, 2012

News Daily News

Danish Study Looks at Impact of Socioeconomic Status on Primary PCI Outcomes

Caitlin E. Cox

October 09, 2012

Presentation

Use of New-Generation Oral Anticoagulant Agents in Patients Receiving Antiplatelet Therapy After an ACS

Presenter: Andr?s Kom?csi

October 01, 2012

Advertisement

In Older ACS Patients, Half-Dose Prasugrel as Safe as Clopidogrel But No More Effective

En Pacientes Ancianos, Media Dosis de Prasugrel es igual de Segura que el Clopidogrel aunque No Más Eficaz

HORIZONS-AMI: Bivalirudin, Taxus Improve Outcomes in LAD PCI Patients

Stroke After STEMI Unusual But Carries Poor Prognosis

Bone Marrow Stem Cells Not Effective Early or Late After AMI

Rivaroxaban Added to Dual Antiplatelet Therapy Cuts Stent Thrombosis in ACS Patients

Danish Registry: Dabigatran Safe, Effective in Real-World Use

Las Hemorragias ‘Molestas’ tras un IAM son Frecuenten e Influyen en la Calidad de Vida

Remote Postconditioning Reduces AKI in NSTEMI Patients

STREAM: Fibrinolysis Strategy Effective for STEMI Patients Far From PCI Hospital

AIDA STEMI Substudy Confirms No Advantage for Intracoronary Abciximab

Una Dosis Alta de Aspirina tras una PCI Primaria aumenta las Hemorragias No observandose Beneficio Isquémico alguno

Genetic Alleles Affect Response to Prasugrel in ACS Patients

Los Alelos Genéticos Influyen en la Respuesta al Prasugrel de los Pacientes víctimas de un SCA

Los betabloqueadores reducen la mortalidad a largo plazo en pacientes de alto riesgo de STEMI

Beta-Blockers Reduce Long-term Mortality in High-Risk STEMI Patients

Second-Generation DES Safer, More Effective Than BMS in STEMI at 1 Year

Almost 1 in 10 STEMIs Caused by Stent Thrombosis

Danish Study Looks at Impact of Socioeconomic Status on Primary PCI Outcomes

Use of New-Generation Oral Anticoagulant Agents in Patients Receiving Antiplatelet Therapy After an ACS

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content